SCLX has been successfully added to your Stock Email Alerts list.
You can manage your stock email alerts here.
SCLX has been removed from your Stock Email Alerts list.
Please enter Portfolio Name for new portfolio.
Shares outstanding are shares that have been authorized, issued, and purchased by investors and are held by them. Scilex Holding Co's shares outstanding for the quarter that ended in Mar. 2024 was 106.12 Mil.
Scilex Holding Co's quarterly shares outstanding increased from Dec. 2023 (100.02 Mil) to Mar. 2024 (106.12 Mil). It means Scilex Holding Co issued new shares from Dec. 2023 to Mar. 2024 .
Scilex Holding Co's annual shares outstanding declined from Dec. 2022 (141.35 Mil) to Dec. 2023 (100.02 Mil). It means Scilex Holding Co bought back shares from Dec. 2022 to Dec. 2023 .
The historical data trend for Scilex Holding Co's Shares Outstanding (EOP) can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Scilex Holding Co Annual Data | |||||||||||
Trend | Dec19 | Dec20 | Dec21 | Dec22 | Dec23 | ||||||
Shares Outstanding (EOP) | 133.05 | 133.05 | 133.05 | 141.35 | 100.02 |
Scilex Holding Co Quarterly Data | ||||||||||||
Dec19 | Dec20 | Dec21 | Mar22 | Jun22 | Sep22 | Dec22 | Mar23 | Jun23 | Sep23 | Dec23 | Mar24 | |
Shares Outstanding (EOP) | Get a 7-Day Free Trial | 145.81 | 148.70 | 94.12 | 100.02 | 106.12 |
For the Drug Manufacturers - General subindustry, Scilex Holding Co's Shares Outstanding (EOP), along with its competitors' market caps and Shares Outstanding (EOP) data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
For the Drug Manufacturers industry and Healthcare sector, Scilex Holding Co's Shares Outstanding (EOP) distribution charts can be found below:
* The bar in red indicates where Scilex Holding Co's Shares Outstanding (EOP) falls into.
Shares outstanding are shares that have been authorized, issued, and purchased by investors and are held by them. They have voting rights and represent ownership in the corporation by the person that holds the shares. They should be distinguished from treasury shares, which are shares held by the corporation itself, having no exercisable rights.
Shares outstanding can be calculated as either basic or fully diluted. The fully diluted shares outstanding count includes diluting securities, such as options, warrants or convertibles.
Please note: GuruFocus named Shares Outstanding (EOP) is the shares for that end of period. It is usually used to calculate balance sheet related items, such as Book Value per Share, etc. While Shares Outstanding (Diluted Average) and Shares Outstanding (Basic Average) are the weighted average shares over a period of time (a year, a quarter, or so). They are usually used to calculate income statement or cashflow statement related items, such as Earnings per Share (Diluted), etc.
Scilex Holding Co (NAS:SCLX) Shares Outstanding (EOP) Explanation
A company may buy back shares or issue shares in any fiscal period. If a company buys back shares, we should observe that the total number of shares decline. If the company issues new shares, the number of shares outstanding increases.
Usually the presence of treasury shares and a history of buyback are good indicators that company has competitive advantage. But studies have shown that companies usually buy back at wrong time. Buying back shares below its intrinsic value increases value for remaining shareholders. Buying back overvalued shares destroys value for existing shareholders.
Be Aware
Warren Buffett looks for consistency and upward long term trend. Because of share repurchase it is possible for net earnings trend to differ from EPS trend. He preferred net income over EPS. The companies with durable competitive advantage companies report higher % net earnings to total revenues.
Important: If a company is showing net earnings history greater than 20% on total revenues, it is probably benefiting from a long term competitive advantage.
If net earnings is less than 10%, likely to be in a highly competitive business.
Thank you for viewing the detailed overview of Scilex Holding Co's Shares Outstanding (EOP) provided by GuruFocus.com. Please click on the following links to see related term pages.
Sclx Stock Acquisition Jv Llc | 10 percent owner | 960 SAN ANTONIO ROAD, PALO ALTO CA 94303 |
Jay Chun | director | C/O SCILEX HOLDING COMPANY, 960 SAN ANTONIO ROAD, PALO ALTO CA 94303 |
Yue Alexander Wu | director | C/O SORRENTO THERAPEUTICS, INC., 9380 JUDICIAL DRIVE, SAN DIEGO CA 92121 |
Stephen Hoi Ma | officer: Chief Financial Officer | C/O SCILEX HOLDING COMPANY, 960 SAN ANTONIO ROAD, PALO ALTO CA 94303 |
Tommy G Thompson | director | 7711 CARONDELET, ST. LOUIS MO 63105 |
Tien-li Lee | director | C/O SCILEX HOLDING COMPANY, 960 SAN ANTONIO ROAD, PALO ALTO CA 94303 |
Sorrento Therapeutics, Inc. | 10 percent owner | 4955 DIRECTORS PLACE, SAN DIEGO CA 92121 |
David Lemus | director | C/O SORRENTO THERAPEUTICS, INC., 4955 DIRECTOR'S PLACE, SAN DIEGO CA 92121 |
Dorman Followwill | director | C/O SORRENTO THERAPEUTICS, INC., 4955 DIRECTOR'S PLACE, SAN DIEGO CA 92121 |
Henry Ji | director, officer: Executive Chairperson | 5370 RUETTE DE MER, SAN DIEGO CA 92130 |
Jaisim Shah | director, officer: See Remarks | C/O PROTINE DESIGN LAB, 37481 MARSTEN DR, NEWARK CA 94560 |
Elizabeth Czerepak | officer: See Remarks | 201 ROUTE 17 NORTH, RUTHERFORD NJ 07070 |
Laura Hamill | director | 333 LAKESIDE DRIVE, FOSTER CITY CA 94404 |
Suneel G Kaji | director | 25/28 OLD BURLINGTON STREET, LONDON X0 W1S 3AN |
Steve Myint | director | C/O VICKERS VANTAGE CORP. I, 1 HARBOURFRONT AVENUE, #16-06, SINGAPORE U0 098632 |
From GuruFocus
By sperokesalga sperokesalga • 05-04-2023
By Marketwired • 10-03-2023
By PRNewswire PRNewswire • 05-30-2023
By Marketwired • 09-13-2023
By Marketwired • 09-12-2023
By sperokesalga sperokesalga • 06-15-2023
By sperokesalga sperokesalga • 06-16-2023
By PRNewswire • 11-17-2023
Disclaimers: GuruFocus.com is not operated by a broker or a dealer. It has an affiliated registered investment adviser, which serves as the subadviser to an exchange traded fund. This investment adviser does not provide advice to individual investors. Under no circumstances does any information posted on GuruFocus.com represent a recommendation to buy or sell a security. The information on this site, and in its related newsletters, is not intended to be, nor does it constitute investment advice or recommendations. The individuals or entities selected as "gurus" may buy and sell securities before and after any particular article and report and information herein is published, with respect to the securities discussed in any article and report posted herein. Gurus may be added or dropped from the GuruFocus site at any time. In no event shall GuruFocus.com be liable to any member, guest or third party for any damages of any kind arising out of the use of any content or other material published or available on GuruFocus.com, or relating to the use of, or inability to use, GuruFocus.com or any content, including, without limitation, any investment losses, lost profits, lost opportunity, special, incidental, indirect, consequential or punitive damages. Past performance is a poor indicator of future performance. The information on this site, and in its related newsletters, is not intended to be, nor does it constitute investment advice or recommendations. The information on this site is in no way guaranteed for completeness, accuracy or in any other way. The gurus listed in this website are not affiliated with GuruFocus.com, LLC. Stock quotes provided by InterActive Data. Fundamental company data provided by Morningstar, updated daily.